Aarti Industries Ltd Q3 FY26 Results & Concall Highlights: Revenue, Margins & Order Book

Q3 FY26 earnings call analysis: revenue, margin, capex, fundraise and order book outlook from management commentary.

Published 17 Jul 2026 | Chemicals & Petrochemicals | Market Cap: ₹17.6K Cr

The company anticipates consistent growth driven by a robust strategy navigating macro challenges. Aarti Industries expects sustainable growth supported by portfolio quality, value chain integration, and disciplined capital allocation.

From Aarti Industries Ltd's Q3 FY26 earnings-call transcript · updated 23 Aug 2026.

Price

527

Market Cap

₹17.6K Cr

P/E Ratio

33.8

How does Aarti Industries Ltd rank in Chemicals & Petrochemicals?

Compare Aarti Industries Ltd against every Chemicals & Petrochemicals company this quarter on revenue, margins and earnings-call signals.

View Chemicals & Petrochemicals leaderboard →

Aarti Industries Ltd — Quarterly revenue & net profit

Revenue Net Profit
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026

Reported quarterly figures (₹ Cr). Latest: revenue ₹2.2K Cr, net profit ₹137 Cr.

Full financials →

📊 Revenue & Sales Performance

  • The company anticipates consistent growth driven by a robust strategy navigating macro challenges.
  • Agrochemical volumes are stable with potential to grow from 17-18% to around 20% of the overall top line, especially post commissioning of Zone 4.
  • MMA volumes have tripled in a year, expected to constitute 30-40% of the portfolio in the next 2-3 years, with geographical diversification into Europe planned.
  • PDCB volumes are increasing due to new customers and growing applications like EVs.
  • Zone 4 commissioning in 2026 will enable flexible product manufacturing for balanced domestic and export sales.
  • The recent US-India trade deal and India-EU FTA are expected to accelerate export volumes.
  • China’s "anti-involution" policy will reduce dumping and support margin and volume recovery.
  • New JVs and capacity expansions in MMA, DCB, and PEDA will contribute to incremental growth opportunities.

See what Aarti Industries Ltd said on profitability & margins — free account, 30 seconds.

🏗️ Capital Expenditure Plans

  • Majority of CAPEX for Zone 4 will be completed in the current year, with only INR 300-400 crore spilling over to next year.
  • Total Zone 4 CAPEX is estimated around INR 1,600 to 1,800 crore.
  • FY27 CAPEX expected to be significantly lower than current year, around INR 1,000 to 1,100 crore.
  • Incremental CAPEX includes MMA capacity expansions, PEDA project, and DCB debottlenecking.
  • No large projects currently in the pipeline beyond Zone 4.
  • Joint Venture with Superform on track for commissioning in Q1 FY27; INR 150 crore investment from each party.
  • JV with RESL progressing; construction underway, commissioning expected H1 FY27.
  • Focus on strategic partnerships with global players enabled by recent trade deals (India-US, India-EU).
  • Continued emphasis on CAPEX discipline and improving CAPEX return profile.

See what Aarti Industries Ltd said on fundraising & capital structure — free account, 30 seconds.

📋 Order Book & Pipeline

The transcript of the Q3 FY26 earnings call for Aarti Industries Limited does not explicitly state details about the current or expected order book or pending orders. However, some relevant insights related to demand and pipeline include: - Multiple growth partnerships and long-term strategic partnership projects are in active discussions, especially after recent trade agreements (India-US trade deal, India-EU FTA). - The company expects accelerated closing of deals and new contracts due to clarity on U.S. tariffs. - There is a strong pipeline of potential contracts and strategic partnerships, particularly in advanced materials and high-value application-led solutions. - Positive developments like JV commissioning (Superform JV expected in Q1 FY27) could contribute to future order inflows. - Management emphasized that when contracts close with certainty, they will announce updates. No precise order book or value of pending orders is disclosed in the transcript.

Key Metrics

How does Aarti Industries Ltd rank vs peers in Chemicals & Petrochemicals?

Pro feature
1Aarti Industries Ltd

See full Chemicals & Petrochemicals sector rankings

Others in Chemicals & Petrochemicals this season

  • CLEAN (Q3 FY26)

    Trade deal with Europe starting in FY '27 to potentially reduce tariffs (5.5%-12%), helping competitiveness against China. Key concall takeaways from Clean…

  • Aether Industries Ltd (Q3 FY26)

    The company currently services Baker Hughes with 8 products in commercial production (Site 4) generating a run rate of INR 60 crores this quarter. Key concall…

  • Kesar Petroproducts Ltd (Q3 FY26)

    Export markets constitute about 40% of sales, served through 7-8 distributors across geographies. Key concall takeaways from Kesar Petroprod.'s Q3 FY26…

  • TATACHEM (Q3 FY26)

    Indian salt capacity expansion of 210 KT per annum with INR 515 crore investment is underway to meet growing demand. Key concall takeaways from Tata…

🔎 Who's planning the most growth?

Companies ranked by management's own guidance — revenue, margins, capex and order book, from every earnings call in India.

See rankings →

Frequently Asked Questions

What were Aarti Industries Ltd Q3 FY26 results?

The company anticipates consistent growth driven by a robust strategy navigating macro challenges. Aarti Industries expects sustainable growth supported by portfolio quality, value chain integration, and disciplined capital allocation.

What is Aarti Industries Ltd share price analysis?

Aarti Industries Ltd currently shows a neutral. The stock trades at a P/E of 33.8 with a market cap of ₹17,627 Cr. Investors should review the full earnings analysis for detailed insights.

Is Aarti Industries Ltd planning capital expenditure?

Majority of CAPEX for Zone 4 will be completed in the current year, with only INR 300-400 crore spilling over to next year.

Keep Aarti Industries Ltd on your radar — track it to get its next earnings analysis in your feed.

This analysis is AI-generated based on publicly available earnings data and concall transcripts. This is not investment advice. Please consult a SEBI-registered advisor before making investment decisions.